
Marilyn G. Macasiano
Examiner (ID: 2397, Phone: (571)270-5205 , Office: P/3688 )
| Most Active Art Unit | 3688 |
| Art Unit(s) | 3688, 3622 |
| Total Applications | 654 |
| Issued Applications | 347 |
| Pending Applications | 61 |
| Abandoned Applications | 258 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7347608
[patent_doc_number] => 20040248097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Interleukin-20 variants and promoters'
[patent_app_type] => new
[patent_app_number] => 10/444765
[patent_app_country] => US
[patent_app_date] => 2003-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7984
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248097.pdf
[firstpage_image] =>[orig_patent_app_number] => 10444765
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/444765 | Interleukin-20 variants and promoters | May 22, 2003 | Abandoned |
Array
(
[id] => 5807653
[patent_doc_number] => 20060094007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Method of identifying pancreatic ductal carcinoma-specific gene using pancreatic ductal cells, method of testing for pdc using said genes, and method of screening pharmaceutical candidate compounds for treating or preventing pdc'
[patent_app_type] => utility
[patent_app_number] => 10/514235
[patent_app_country] => US
[patent_app_date] => 2003-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 24238
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20060094007.pdf
[firstpage_image] =>[orig_patent_app_number] => 10514235
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/514235 | Method of identifying pancreatic ductal carcinoma-specific gene using pancreatic ductal cells, method of testing for pdc using said genes, and method of screening pharmaceutical candidate compounds for treating or preventing pdc | May 21, 2003 | Abandoned |
Array
(
[id] => 7364801
[patent_doc_number] => 20040005639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-08
[patent_title] => 'Glycerylaldehyde-3-phosphate dehyrogenase promoter inducing cell death'
[patent_app_type] => new
[patent_app_number] => 10/343921
[patent_app_country] => US
[patent_app_date] => 2003-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3091
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20040005639.pdf
[firstpage_image] =>[orig_patent_app_number] => 10343921
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/343921 | Glycerylaldehyde-3-phosphate dehyrogenase promoter inducing cell death | May 20, 2003 | Abandoned |
Array
(
[id] => 7474604
[patent_doc_number] => 20040055024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'Conditional mutants of influenza virus M2 protein'
[patent_app_type] => new
[patent_app_number] => 10/435723
[patent_app_country] => US
[patent_app_date] => 2003-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6721
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20040055024.pdf
[firstpage_image] =>[orig_patent_app_number] => 10435723
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/435723 | Conditional mutants of influenza virus M2 protein | May 7, 2003 | Abandoned |
Array
(
[id] => 7019459
[patent_doc_number] => 20050221478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Control of es cell self renewal and lineage specification, and medium therefor'
[patent_app_type] => utility
[patent_app_number] => 10/513675
[patent_app_country] => US
[patent_app_date] => 2003-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5810
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20050221478.pdf
[firstpage_image] =>[orig_patent_app_number] => 10513675
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/513675 | Control of es cell self renewal and lineage specification, and medium therefor | May 7, 2003 | Abandoned |
Array
(
[id] => 6865207
[patent_doc_number] => 20030190733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Desaturase genes and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/431952
[patent_app_country] => US
[patent_app_date] => 2003-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19533
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20030190733.pdf
[firstpage_image] =>[orig_patent_app_number] => 10431952
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/431952 | Desaturase genes and uses thereof | May 7, 2003 | Issued |
Array
(
[id] => 6701642
[patent_doc_number] => 20030224522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => 'Methods for delivering nucleic acid molecules into cells and assessment thereof'
[patent_app_type] => new
[patent_app_number] => 10/428653
[patent_app_country] => US
[patent_app_date] => 2003-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31440
[patent_no_of_claims] => 84
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20030224522.pdf
[firstpage_image] =>[orig_patent_app_number] => 10428653
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/428653 | Methods for delivering nucleic acid molecules into cells and assessment thereof | Apr 30, 2003 | Abandoned |
Array
(
[id] => 616319
[patent_doc_number] => 07144730
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-12-05
[patent_title] => 'Lipoxygenase proteins and polynucleotides encoding the same'
[patent_app_type] => utility
[patent_app_number] => 10/422264
[patent_app_country] => US
[patent_app_date] => 2003-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17774
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/144/07144730.pdf
[firstpage_image] =>[orig_patent_app_number] => 10422264
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/422264 | Lipoxygenase proteins and polynucleotides encoding the same | Apr 22, 2003 | Issued |
Array
(
[id] => 7364705
[patent_doc_number] => 20040092010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-13
[patent_title] => 'Method of proliferating and inducing brain stem cells to differentiate to neurons'
[patent_app_type] => new
[patent_app_number] => 10/414267
[patent_app_country] => US
[patent_app_date] => 2003-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 21941
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20040092010.pdf
[firstpage_image] =>[orig_patent_app_number] => 10414267
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/414267 | Method of proliferating and inducing brain stem cells to differentiate to neurons | Apr 14, 2003 | Abandoned |
Array
(
[id] => 6846813
[patent_doc_number] => 20030165980
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Methods for diagnosis, prediction and treatment of asthma and other inflammatory conditions based on eotaxin coding sequence polymorphism'
[patent_app_type] => new
[patent_app_number] => 10/413255
[patent_app_country] => US
[patent_app_date] => 2003-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3355
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20030165980.pdf
[firstpage_image] =>[orig_patent_app_number] => 10413255
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/413255 | Methods for diagnosis, prediction and treatment of asthma and other inflammatory conditions based on eotaxin coding sequence polymorphism | Apr 13, 2003 | Issued |
Array
(
[id] => 6829721
[patent_doc_number] => 20030180779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Discovery and diagnostic methods using 5-methylcytosine DNA glycosylase'
[patent_app_type] => new
[patent_app_number] => 10/389853
[patent_app_country] => US
[patent_app_date] => 2003-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15130
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20030180779.pdf
[firstpage_image] =>[orig_patent_app_number] => 10389853
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/389853 | Discovery and diagnostic methods using 5-methylcytosine DNA glycosylase | Mar 13, 2003 | Issued |
Array
(
[id] => 7149584
[patent_doc_number] => 20050120404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => 'Cell division and proliferation preferred regulatory elements and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/388359
[patent_app_country] => US
[patent_app_date] => 2003-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 8143
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20050120404.pdf
[firstpage_image] =>[orig_patent_app_number] => 10388359
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/388359 | Cell division and proliferation preferred regulatory elements and uses thereof | Mar 12, 2003 | Abandoned |
Array
(
[id] => 6729619
[patent_doc_number] => 20030185809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Mixed-cell gene therapy'
[patent_app_type] => new
[patent_app_number] => 10/382137
[patent_app_country] => US
[patent_app_date] => 2003-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10590
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20030185809.pdf
[firstpage_image] =>[orig_patent_app_number] => 10382137
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/382137 | Mixed-cell gene therapy | Mar 4, 2003 | Issued |
Array
(
[id] => 7134608
[patent_doc_number] => 20040043394
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-04
[patent_title] => 'Gene expression element specific for Ah receptor ligands and heterologous gene expression systems dependent on the element'
[patent_app_type] => new
[patent_app_number] => 10/375269
[patent_app_country] => US
[patent_app_date] => 2003-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9939
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20040043394.pdf
[firstpage_image] =>[orig_patent_app_number] => 10375269
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/375269 | Gene expression element specific for Ah receptor ligands and heterologous gene expression systems dependent on the element | Mar 2, 2003 | Abandoned |
Array
(
[id] => 6829244
[patent_doc_number] => 20030180302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances'
[patent_app_type] => new
[patent_app_number] => 10/376564
[patent_app_country] => US
[patent_app_date] => 2003-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 26651
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20030180302.pdf
[firstpage_image] =>[orig_patent_app_number] => 10376564
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/376564 | Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances | Feb 27, 2003 | Abandoned |
Array
(
[id] => 7679166
[patent_doc_number] => 20030167486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Double transgenic mice overexpressing human beta secretase and human APP-London'
[patent_app_type] => new
[patent_app_number] => 10/372730
[patent_app_country] => US
[patent_app_date] => 2003-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 17258
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20030167486.pdf
[firstpage_image] =>[orig_patent_app_number] => 10372730
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/372730 | Double transgenic mice overexressing human beta secretase and human APP-London | Feb 23, 2003 | Issued |
Array
(
[id] => 7097699
[patent_doc_number] => 20050130158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Screening method'
[patent_app_type] => utility
[patent_app_number] => 10/502770
[patent_app_country] => US
[patent_app_date] => 2003-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7374
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20050130158.pdf
[firstpage_image] =>[orig_patent_app_number] => 10502770
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/502770 | Screening method | Feb 17, 2003 | Abandoned |
Array
(
[id] => 6706291
[patent_doc_number] => 20030153025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-14
[patent_title] => 'Cell-based drug screens for regulators of gene expression'
[patent_app_type] => new
[patent_app_number] => 10/365958
[patent_app_country] => US
[patent_app_date] => 2003-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6167
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20030153025.pdf
[firstpage_image] =>[orig_patent_app_number] => 10365958
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/365958 | Cell-based drug screens for regulators of gene expression | Feb 12, 2003 | Issued |
Array
(
[id] => 6847700
[patent_doc_number] => 20030166867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Fibrin nanoparticles and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/353800
[patent_app_country] => US
[patent_app_date] => 2003-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6226
[patent_no_of_claims] => 84
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166867.pdf
[firstpage_image] =>[orig_patent_app_number] => 10353800
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/353800 | Fibrin nanoparticles and uses thereof | Jan 28, 2003 | Abandoned |
Array
(
[id] => 6658921
[patent_doc_number] => 20030134270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-17
[patent_title] => 'Rapid method of selecting cells for gene disruption by homologous recombination'
[patent_app_type] => new
[patent_app_number] => 10/345130
[patent_app_country] => US
[patent_app_date] => 2003-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8095
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 189
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20030134270.pdf
[firstpage_image] =>[orig_patent_app_number] => 10345130
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/345130 | Rapid method of selecting cells for gene disruption by homologous recombination | Jan 13, 2003 | Abandoned |